Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
September 29, 2015
0Patent Application Number
145163370
Date Filed
October 16, 2014
0Patent Citations Received
Patent Primary Examiner
Patent abstract
The object is to provide an Fms-like tyrosine kinase 3 (FLT3) inhibitor useful as a therapeutic agent for acute myeloid leukemia (AML). A novel nitrogen-containing heterocyclic compound represented by the general formula [1] or a salt thereof is provided. The compound or a salt thereof of the present invention can be used as an active ingredient of a pharmaceutical composition for a treatment of a disease or condition relating to FLT3, such as acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL).
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
